The scientific focus adapted
to express the optimum potential
of your molecule

Unparalleled vision in metabolic disorders and risk assessment expertise for post-marketing studies and drug repositioning.

HeartArteryMacrophageLiverMusclePancreasAdipose Tissue

Preclinical development:
In-house predictive models and tracer technologies enable the generation of Proof of Concept efficacy data for your drugs.

Screening and lead validation utilize a dedicated research platform which combine with our focused scientific vision.

Home > Growth inhibition assay in HCC cell lines

Liver cancer cell lines screening

In vitro growth inhibition assay for drugs targeting hepatocellular carcinoma

Key benefits

  • Compound screening in liver cancer cell lines
  • Evaluate the antitumor activity of your compounds on hetapoma cell lines (IC50)
  • Tumor cell line screening



  • Mouse : Hepa1-6
  • Human: HuH-7

Reference compound

  • Sorafenib

Parameters evaluated

  • Determination of inhibition growth (IC50)

in vitro growth inhibition assay in hepatoma cell lines
in vitro growth inhibition assay in hepatoma cell lines

Add-on studies

  • Orthotopic or metastatic tumor in vivo models using the same cell lines as above